Jessica Sorrentino

Person

Durham, NC, US

People

Patents Grantslast 30 patents

Information Patent Grant
Preservation of immune response during chemotherapy regimens
- Patent number 11,529,352
- Issue date Dec 20, 2022
- G1 Therapeutics, Inc.
- Jessica A. Sorrentino
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Anti-neoplastic combinations and dosing regimens using CDK4/6 inhib...
- Patent number 11,446,295
- Issue date Sep 20, 2022
- G1 Therapeutics, Inc.
- Jay Copeland Strum
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Treatment of EGFR-driven cancer with fewer side effects
- Patent number 11,395,821
- Issue date Jul 26, 2022
- G1 Therapeutics, Inc.
- Jessica A. Sorrentino
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Treatment of Rb-negative tumors using topoisomerase inhibitors in c...
- Patent number 11,090,306
- Issue date Aug 17, 2021
- G1 Therapeutics, Inc.
- Jay Copeland Strum
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Treatment of Rb-negative tumors using topoisomerase with cyclin dep...
- Patent number 10,413,547
- Issue date Sep 17, 2019
- G1 Therapeutics, Inc.
- Jay Copeland Strum
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Anti-neoplastic combinations and dosing regimens using CDK4/6 inhib...
- Patent number 10,231,969
- Issue date Mar 19, 2019
- GI Therapeutics, Inc.
- Jay Copeland Strum
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
PRESERVATION OF IMMUNE RESPONSE DURING CHEMOTHERAPY REGIMENS
- Publication number 20230302001
- Publication date Sep 28, 2023
- G1 Therapeutics, Inc.
- Jessica A. Sorrentino
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTI-NEOPLASTIC COMBINATIONS AND DOSING REGIMENS USING CDK4/6 INHIB...
- Publication number 20230241059
- Publication date Aug 3, 2023
- G1 Therapeutics, Inc.
- Jay Copeland Strum
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Treatment of EGFR-Driven Cancer with Fewer Side Effects
- Publication number 20230146638
- Publication date May 11, 2023
- G1 Therapeutics, Inc.
- Jessica A. Sorrentino
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PATIENT SELECTION FOR ENHANCEMENT OF ANTI-TUMOR IMMUNITY IN CANCER...
- Publication number 20220175787
- Publication date Jun 9, 2022
- G1 Therapeutics Inc.
- Patrick Joseph Roberts
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TREATMENT OF RB-NEGATIVE TUMORS USING TOPOISOMERASE INHIBITORS IN C...
- Publication number 20220175780
- Publication date Jun 9, 2022
- G1 Therapeutics, Inc.
- Jay Copeland Strum
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
THERAPEUTIC REGIMENS FOR TREATMENT OF CANCER USING ERIBULIN AND SEL...
- Publication number 20210267986
- Publication date Sep 2, 2021
- G1 Therapeutics, Inc.
- Jessica A. Sorrentino
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TREATMENT OF CANCERS HAVING DRIVING ONCOGENIC MUTATIONS
- Publication number 20210030758
- Publication date Feb 4, 2021
- G1 Therapeutics, Inc.
- Jay Copeland Strum
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TREATMENT OF RB-NEGATIVE TUMORS USING TOPOISOMERASE INHIBITORS IN C...
- Publication number 20200022983
- Publication date Jan 23, 2020
- G1 Therapeutics, Inc.
- Jay Copeland Strum
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TREATMENT OF EGFR-DRIVEN CANCER WITH FEWER SIDE EFFECTS
- Publication number 20190374545
- Publication date Dec 12, 2019
- G1 Therapeutics, Inc.
- Jessica A. Sorrentino
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PRESERVATION OF IMMUNE RESPONSE DURING CHEMOTHERAPY REGIMENS
- Publication number 20190321370
- Publication date Oct 24, 2019
- G1 Therapeutics, Inc.
- Jessica A. Sorrentino
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTI-NEOPLASTIC COMBINATIONS AND DOSING REGIMENS USING CDK4/6 INHIB...
- Publication number 20190151311
- Publication date May 23, 2019
- G1 Therapeutics, Inc.
- Jay Copeland Strum
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TREATMENT OF RB-NEGATIVE TUMORS USING TOPOISOMERASE INHIBITORS IN C...
- Publication number 20190030034
- Publication date Jan 31, 2019
- G1 Therapeutics, Inc.
- Jay Copeland Strum
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Treatment Of RB-Negative Tumors Using Topoisomerase Inhibitors In C...
- Publication number 20170246171
- Publication date Aug 31, 2017
- G1 Therapeutics, Inc.
- Jay Copeland Strum
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Anti-Neoplastic Combinations and Dosing Regimens using CDK4/6 Inhib...
- Publication number 20170182043
- Publication date Jun 29, 2017
- G1 Therapeutics, Inc.
- Jay Copeland Strum
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CDK4/6 Inhibitor Dosage Formulations For The Protection Of Hematopo...
- Publication number 20160220569
- Publication date Aug 4, 2016
- G1 Therapeutics, Inc.
- Jay Copeland Strum
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Jessica Sorrentino

Person

Patents Grantslast 30 patents

Preservation of immune response during chemotherapy regimens

Anti-neoplastic combinations and dosing regimens using CDK4/6 inhib...

Treatment of EGFR-driven cancer with fewer side effects

Treatment of Rb-negative tumors using topoisomerase inhibitors in c...

Treatment of Rb-negative tumors using topoisomerase with cyclin dep...

Anti-neoplastic combinations and dosing regimens using CDK4/6 inhib...

Patents Applicationslast 30 patents

PRESERVATION OF IMMUNE RESPONSE DURING CHEMOTHERAPY REGIMENS

ANTI-NEOPLASTIC COMBINATIONS AND DOSING REGIMENS USING CDK4/6 INHIB...

Treatment of EGFR-Driven Cancer with Fewer Side Effects

PATIENT SELECTION FOR ENHANCEMENT OF ANTI-TUMOR IMMUNITY IN CANCER...

TREATMENT OF RB-NEGATIVE TUMORS USING TOPOISOMERASE INHIBITORS IN C...

THERAPEUTIC REGIMENS FOR TREATMENT OF CANCER USING ERIBULIN AND SEL...

TREATMENT OF CANCERS HAVING DRIVING ONCOGENIC MUTATIONS

TREATMENT OF RB-NEGATIVE TUMORS USING TOPOISOMERASE INHIBITORS IN C...

TREATMENT OF EGFR-DRIVEN CANCER WITH FEWER SIDE EFFECTS

PRESERVATION OF IMMUNE RESPONSE DURING CHEMOTHERAPY REGIMENS

ANTI-NEOPLASTIC COMBINATIONS AND DOSING REGIMENS USING CDK4/6 INHIB...

TREATMENT OF RB-NEGATIVE TUMORS USING TOPOISOMERASE INHIBITORS IN C...

Treatment Of RB-Negative Tumors Using Topoisomerase Inhibitors In C...

Anti-Neoplastic Combinations and Dosing Regimens using CDK4/6 Inhib...

CDK4/6 Inhibitor Dosage Formulations For The Protection Of Hematopo...